Clinical Trials Logo

Clinical Trial Summary

Kinesiophobia is a common problem in patients with rheumatic disease and can cause physical inactivity, social isolation, disability, and poor quality of life. This study aimed to evaluate kinesiophobia and associated factors in patients with familial Mediterranean fever (FMF). All patients were evaluated in terms of sociodemographic characteristics and assessed using the Tampa Kinesiophobia Scale (TKS), International Physical Activity Questionnaire (IPAQ), Fatigue Severity Scale (FSS), and Hospital Anxiety and Depression Scale (HADS).


Clinical Trial Description

Familial Mediterranean fever (FMF) is a common autoinflammatory disease among certain ethnic groups living in the Mediterranean basin. The reported prevalence of FMF among children in Turkey is 9.3/10000. Kinesiophobia is a common problem in patients with rheumatic disease and can cause physical inactivity, social isolation, disability, and poor quality of life. This study aimed to evaluate kinesiophobia and associated factors in patients with familial Mediterranean fever (FMF). All patients were evaluated in terms of sociodemographic characteristics and assessed using the Tampa Kinesiophobia Scale (TKS), International Physical Activity Questionnaire (IPAQ), Fatigue Severity Scale (FSS), and Hospital Anxiety and Depression Scale (HADS). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05398536
Study type Observational
Source Halic University
Contact
Status Completed
Phase
Start date January 8, 2018
Completion date December 20, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05190991 - Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever Phase 2
Recruiting NCT03210610 - Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients
Not yet recruiting NCT06336733 - Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy Phase 3
Not yet recruiting NCT05292768 - Are Mast Cells Involved in Autoinflammatory Diseases
Enrolling by invitation NCT04402255 - Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. N/A
Completed NCT02466217 - Phenomics in Autoimmune and Inflammatory Diseases
Recruiting NCT05980780 - The Effect of Video Game on Children With Familial Mediterranean Fever N/A
Not yet recruiting NCT06047938 - FMF and Atheroscelerosis
Recruiting NCT05092776 - Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine Phase 2
Enrolling by invitation NCT04403438 - Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic